Back to Search
HANI KHOURY, MD
MD
Colon & Rectal Surgery Physician
NPI: 1558440925Individual
Specialties, Licenses & Credentials
Colon & Rectal Surgery PhysicianPrimary
Colon & Rectal Surgery
Code: 208C00000X
25MA03399800(NJ)
Research & Publications (20)
Metabolism evaluation of biomimetic prodrugs by in vitro models and mass spectrometry.
PMID 19467308·Int J Pharm·2009
4-observational
The influence of using Jordanian natural zeolite on the adsorption, physical, and mechanical properties of geopolymers products.
PMID 19036505·J Hazard Mater·2009
8-other
Prior rituximab correlates with less acute graft-versus-host disease and better survival in B-cell lymphoma patients who received allogeneic peripheral blood stem cell transplantation.
PMID 19344418·Br J Haematol·2009
8-other
To G or not to G: is this still a question in allogeneic transplantation?
PMID 19279560·Bone Marrow Transplant·2009
8-other
Dasatinib in the treatment of chronic myeloid leukemia in accelerated phase after imatinib failure: the START a trial.
PMID 19487385·J Clin Oncol·2009
3-trial
Phase 3 study of dasatinib 140 mg once daily versus 70 mg twice daily in patients with chronic myeloid leukemia in accelerated phase resistant or intolerant to imatinib: 15-month median follow-up.
PMID 19369231·Blood·2009
3-trial
Fibroblast growth factor receptor 3 associates with and tyrosine phosphorylates p90 RSK2, leading to RSK2 activation that mediates hematopoietic transformation.
PMID 19223461·Mol Cell Biol·2009
7-preclinical
Dasatinib treatment for Philadelphia chromosome-positive leukemias: practical considerations.
PMID 19195046·Cancer·2009
6-review
Serine/arginine protein-specific kinase 2 promotes leukemia cell proliferation by phosphorylating acinus and regulating cyclin A1.
PMID 18559500·Cancer Res·2008
8-other
CALDose_X-a software tool for the assessment of organ and tissue absorbed doses, effective dose and cancer risks in diagnostic radiology.
PMID 18941276·Phys Med Biol·2008
8-other
Assessment of dosimetric quantities for patients undergoing X-ray examinations in a large public hospital in Brazil--a preliminary study.
PMID 18786933·Radiat Prot Dosimetry·2008
8-other
Efficacy and safety of dasatinib in imatinib-resistant or -intolerant patients with chronic myeloid leukemia in blast phase.
PMID 18754032·Leukemia·2008
3-trial
Impact of prior imatinib mesylate on the outcome of hematopoietic cell transplantation for chronic myeloid leukemia.
PMID 18664621·Blood·2008
8-other
Epidermal growth factor stimulates RSK2 activation through activation of the MEK/ERK pathway and src-dependent tyrosine phosphorylation of RSK2 at Tyr-529.
PMID 18156174·J Biol Chem·2008
7-preclinical
Targeting 14-3-3 sensitizes native and mutant BCR-ABL to inhibition with U0126, rapamycin and Bcl-2 inhibitor GX15-070.
PMID 18079735·Leukemia·2008
8-other
Intermittent target inhibition with dasatinib 100 mg once daily preserves efficacy and improves tolerability in imatinib-resistant and -intolerant chronic-phase chronic myeloid leukemia.
PMID 18541900·J Clin Oncol·2008
3-trial
Squalenoylation favorably modifies the in vivo pharmacokinetics and biodistribution of gemcitabine in mice.
PMID 18474674·Drug Metab Dispos·2008
7-preclinical
Evidence and Value: Impact on DEcisionMaking--the EVIDEM framework and potential applications.
PMID 19102752·BMC Health Serv Res·2008
6-review
Long-term progression-free survival after early autologous transplantation for mantle-cell lymphoma.
PMID 18622414·Bone Marrow Transplant·2008
8-other
Silicone gel implants in breast augmentation and reconstruction.
PMID 17992156·Ann Plast Surg·2007
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 502 HAMBURG TPK, SUITE 107
WAYNE, NJ 07470 - Phone
- (973) 942-6611
Quick Facts
- NPI
- 1558440925
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile